Literature DB >> 26687989

The Role of the Fibroblast in Inflammatory Upper Airway Conditions.

Stephen L Ball1, Derek A Mann2, Janet A Wilson3, Andrew J Fisher2.   

Abstract

Upper airway inflammation is one of the most frequent health care presentations. This is perhaps not surprising with our exposure to a myriad of environmental microbes, pollutants, and allergens. The precise pathophysiological mechanisms that cause persistent, exaggerated, upper airway inflammation rather than acute resolving illness remain unclear. Analysis of upper airway specimens identifies specific inflammatory cells, cytokine signatures, and fibrotic airway remodeling. Recent research has highlighted the role of stromal cells in the generation and persistence of chronic inflammation. Rather than simply being scaffolding or extracellular matrix-secreting cells on which organ systems are built, stromal cells including fibroblasts and osteocytes have their own independent immunologic functions. Here, we review the emerging inflammatory roles of upper airway fibroblasts, the majority of which appear to influence immune cell chemotaxis and amplify the inflammatory response.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26687989      PMCID: PMC4729240          DOI: 10.1016/j.ajpath.2015.09.020

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  Role of platelet-derived growth factor in airway remodeling in rhinosinusitis.

Authors:  Hideaki Kouzaki; Satoshi Seno; Jun Fukui; Shigehiro Owaki; Takeshi Shimizu
Journal:  Am J Rhinol Allergy       Date:  2009 May-Jun       Impact factor: 2.467

2.  Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure.

Authors:  Devyani Lal; Joseph M Scianna; James A Stankiewicz
Journal:  Am J Rhinol Allergy       Date:  2009 Jul-Aug       Impact factor: 2.467

3.  Combined stimulation with Poly(I:C), TNF-alpha and Th2 cytokines induces TARC production by human fibroblasts from the nose, bronchioles and lungs.

Authors:  Manabu Nonaka; Nozomu Ogihara; Akira Fukumoto; Atsuko Sakanushi; Kaoru Kusama; Ruby Pawankar; Toshiaki Yagi
Journal:  Int Arch Allergy Immunol       Date:  2010-02-26       Impact factor: 2.749

4.  Poly(I:C) induces BLyS-expression of airway fibroblasts through phosphatidylinositol 3-kinase.

Authors:  Takechiyo Yamada; Su Lizhong; Noboru Takahashi; Seita Kubo; Norihiko Narita; Dai Suzuki; Tetsuji Takabayashi; Yuichi Kimura; Shigeharu Fujieda
Journal:  Cytokine       Date:  2010-01-20       Impact factor: 3.861

5.  Expression of transcription factors NF-kappaB and AP-1 in nasal polyposis.

Authors:  F C P Valera; R Queiroz; C Scrideli; L G Tone; W T Anselmo-Lima
Journal:  Clin Exp Allergy       Date:  2008-04       Impact factor: 5.018

6.  Expression of MCP-4 by TLR ligand-stimulated nasal polyp fibroblasts.

Authors:  Manabu Nonaka; Akira Fukumoto; Nozomu Ogihara; Ruby Pawankar; Atsuko Sakanushi; Toshiaki Yagi
Journal:  Acta Otolaryngol       Date:  2007-12       Impact factor: 1.494

Review 7.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

8.  American Rhinologic Society member survey on "maximal medical therapy" for chronic rhinosinusitis.

Authors:  Marc G Dubin; Cindy Liu; Sandra Y Lin; Brent A Senior
Journal:  Am J Rhinol       Date:  2007 Jul-Aug

9.  The inhibitory effects of macrolide antibiotics on bone remodeling in chronic rhinosinusitis.

Authors:  Chan-Soon Park; Yong-Soo Park; Yong-Jin Park; Jin-Hee Cho; Jun-Myung Kang; Soo-Yeon Kim
Journal:  Otolaryngol Head Neck Surg       Date:  2007-08       Impact factor: 3.497

10.  Influence of vitamin D(3) analogues in combination with budesonid R on proliferation of nasal polyp fibroblasts.

Authors:  Beata Rostkowska-Nadolska; Marcin Fraczek; Wojciech Gawron; Małgorzata Latocha
Journal:  Acta Biochim Pol       Date:  2009-06-06       Impact factor: 2.149

View more
  8 in total

1.  Leonurus sibiricus root extracts decrease airway remodeling markers expression in fibroblasts.

Authors:  J Wieczfinska; P Sitarek; T Kowalczyk; R Pawliczak
Journal:  Clin Exp Immunol       Date:  2020-07-18       Impact factor: 4.330

Review 2.  Versican: A Dynamic Regulator of the Extracellular Matrix.

Authors:  Shamima Islam; Hideto Watanabe
Journal:  J Histochem Cytochem       Date:  2020-09-10       Impact factor: 2.479

3.  Baicalin Down-Regulates IL-1β-Stimulated Extracellular Matrix Production in Nasal Fibroblasts.

Authors:  Jae-Min Shin; Ju-Hyung Kang; Seoung-Ae Lee; Il-Ho Park; Heung-Man Lee
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

4.  Memory-type ST2+CD4+ T cells participate in the steroid-resistant pathology of eosinophilic pneumonia.

Authors:  Naoko Mato; Kiyoshi Hirahara; Tomomi Ichikawa; Jin Kumagai; Masayuki Nakayama; Hideaki Yamasawa; Masashi Bando; Koichi Hagiwara; Yukihiko Sugiyama; Toshinori Nakayama
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

Review 5.  Roles of Exosomes in Chronic Rhinosinusitis: A Systematic Review.

Authors:  Karolina Dżaman; Katarzyna Czerwaty
Journal:  Int J Mol Sci       Date:  2022-09-25       Impact factor: 6.208

Review 6.  New targets for resolution of airway remodeling in obstructive lung diseases.

Authors:  Ajay P Nayak; Deepak A Deshpande; Raymond B Penn
Journal:  F1000Res       Date:  2018-05-30

7.  Effects of ozone stimulation of bronchial epithelial cells on proliferation and collagen synthesis of co-cultured lung fibroblasts.

Authors:  Yue Wang; Meiling Tan; Haiping Ouyang; Linhong Deng
Journal:  Exp Ther Med       Date:  2018-05-02       Impact factor: 2.447

8.  Protective Effects of Casticin From Vitex trifolia Alleviate Eosinophilic Airway Inflammation and Oxidative Stress in a Murine Asthma Model.

Authors:  Chian-Jiun Liou; Ching-Yi Cheng; Kuo-Wei Yeh; Yi-Hong Wu; Wen-Chung Huang
Journal:  Front Pharmacol       Date:  2018-06-14       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.